The 'Tyranny of choices' in the ingestion-controlling network
- PMID: 20090389
- PMCID: PMC2878589
- DOI: 10.1159/000260906
The 'Tyranny of choices' in the ingestion-controlling network
Abstract
Background: Currently used antiobesity remedies offer only a modest weight reduction, and have untoward effects that can complicate treatment efforts. Motivated by the needs of the pharmacotherapy of obesity, the study explored the role of neuropeptide Y, leptin, and corticotrophin-releasing hormone.
Method: The study used Ingenuity Pathway Analysis which is a tool for automated discovery and visualization of molecular interactions.
Results: In ingestion-controlling networks, neuropeptide Y, leptin, and corticotrophin-releasing hormone molecules are commonly combined into the units designated as 'maximal motifs'. The analysis of this triad allowed suggesting that maximal motifs are not more than a compendium of admission rules and transmission alternatives of their nodes catalogued in the dataset. Nonetheless, these options seem to endow them with the flexibility needed to respond dynamically as a functional unit to changing internal (metabolic) conditions or environmental challenges.
Conclusion: Thus far, each peptide represents a separate target for pharmaceutical interventions (as judged by US patents scanned). The study concludes with predictions regarding designs of 'multitargeted' antiobesity agents since only by hitting a combination of targets can an appropriate therapeutic effect be achieved.
Copyright 2009 S. Karger AG, Basel.
Figures



Similar articles
-
Current and investigational antiobesity agents and obesity therapeutic treatment targets.Obes Res. 2004 Aug;12(8):1197-211. doi: 10.1038/oby.2004.151. Obes Res. 2004. PMID: 15340100 Review.
-
Obesity drug pipeline not so fat.Science. 2003 Feb 7;299(5608):849-52. doi: 10.1126/science.299.5608.849. Science. 2003. PMID: 12574616 No abstract available.
-
Leptin and Adiponectin Signaling Pathways Are Involved in the Antiobesity Effects of Peanut Skin Extract.Oxid Med Cell Longev. 2019 Oct 14;2019:2935315. doi: 10.1155/2019/2935315. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31737168 Free PMC article.
-
The hypothalamic-pituitary-adrenal axis in the neuroendocrine regulation of food intake and obesity: the role of corticotropin releasing hormone.Nutr Neurosci. 2004 Oct-Dec;7(5-6):271-80. doi: 10.1080/10284150400020516. Nutr Neurosci. 2004. PMID: 15682923 Review.
-
Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins.Bioessays. 2001 Dec;23(12):1095-9. doi: 10.1002/bies.10018. Bioessays. 2001. PMID: 11746228 Review.
Cited by
-
Ingestion-controlling network: what's language got to do with it?Rev Neurosci. 2010;21(1):67-81. doi: 10.1515/revneuro.2010.21.1.67. Rev Neurosci. 2010. PMID: 20458888 Free PMC article. Review.
-
Contents of this issue.Obes Facts. 2009;2(6):342-3. doi: 10.1159/000265935. Epub 2009 Dec 29. Obes Facts. 2009. PMID: 20090383 Free PMC article. No abstract available.
References
-
- Finkelstein E, Fiebelkorn I, Wang GJ: National medical spending attributable to overweight and obesity: how much, and who's paying. Health Affairs 2003; content.healthaffairs.org/cgi/content/short/hlthaff.w3.219v1 - PubMed
-
- Rao CV, Arkin AP. Control motifs for intracellular regulatory networks. Annu Rev Biomed Eng. 2001;3:391–419. - PubMed
-
- Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. Network motifs: simple building blocks of complex networks. Science. 2002;298:824–827. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical